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Abstract.  The adhesive extracellular matrix  glycopro- 
tein fibronectin (FN) is thought to play an important 
role in the cell migration  associated with wound heal- 
ing.  Immunolocalization  studies show abundant FN in 
healing  wounds; however, these studies cannot define 
the cellular site(s) of FN synthesis, nor do they distin- 
guish the different and potentially functionally distinct 
forms of FN that can arise from alternative  splicing of 
the primary gene transcript.  To examine these ques- 
tions of FN synthesis and  splicing during  wound heal- 
ing,  we have performed in situ hybridization with 
segment-specific probes on healing  wounds in adult rat 
skin.  We find that the FN gene is expressed at in- 
creased levels after wounding both in the cells at the 
base of the wound and  in subjacent muscle and dermis 
lateral to the wound.  Interestingly,  however, the pattern 
of splicing of FN mRNA was different in these areas. 
In adjacent dermis and muscle, the splicing pattern re- 
mains identical  with that seen in normal adult rat 
skin,  with two of the three spliced segments (EIIIA 
and EIIIB) excluded from FN mRNA.  In contrast, 
these two segments are included in the FN mRNA 
present in the cells at the base of the wound.  As a  re- 
sult,  the mRNA in this region is spliced in a pattern 
identical  with that found during early embryogenesis. 
The finding that the pattern of FN splicing during 
wound healing  resembles an embryonic pattern sug- 
gests that alternative  splicing may be used during 
wound healing as a mechanism to generate forms of 
FN that may be functionally more appropriate  for the 
cell migration  and proliferation associated with tissue 
repair. 
T 
hE ability to repair damaged tissue, wound healing, 
represents an important response to injury that is com- 
mon to all complex organisms.  Just as in embyronic 
development, this process involves cell proliferation,  migra- 
tion, and differentiation  of a number of different cell types 
(Clark  and  Henson,  1988).  It therefore seems likely that 
wound healing  might  share many of the molecular mecha- 
nisms used during  development.  A number of studies  have 
examined the role of the adhesive extracellular  matrix glyco- 
protein fibronectin  (FN),~ which has been shown to play an 
important  role in embryonic cell migration.  FN promotes 
cell migration  in culture (Ali and Hynes,  1978; Rovasio et 
al., 1983) and is present in the embryo associated with many 
different cell migrations  (Critchley et al., 1979; Kurkinen et 
al.,  1979; Newgreen and Thiery,  1980; Mayer et al.,  1981; 
Heasman et al.,  1981; Duband and Thiery,  1982; Thiery et 
al.,  1982;  Linask  and  Lash,  1986;  Kitten  et  al.,  1987; 
Dufour et al., 1988). In addition,  antibodies to FN (Boucaut 
et al., 1984; Poole and Thiery,  1986) or to cell surface recep- 
tors  of the  integrin  glycoprotein  family  (Bronner-Fraser, 
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type III repeats; FN,  fibronectin; nt, nucleotide; V, nonhomologous seg- 
ment lying between two type 11I repeats. 
1985, 1986) can block migration  when injected into the in- 
tact embryo. 
FN is expressed at high levels in healing  wounds (Kurki- 
nen et al.,  1980; Grinnell  et al.,  1981; Clark et al.,  1982a, 
b) and is derived from two sources: plasma FN (pFN), which 
is present in the exudate  from damaged blood vessels; and 
"cellular" FN, which is synthesized locally in the wound tis- 
sue (Clark et al., 1983). It seems likely that FN plays an im- 
portant role in wound healing as it appears to be involved in 
the migration  in vitro of four major cell types that migrate 
into the area of the wound. Fibroblasts and epidermal cells 
(keratinocytes)  are  stimulated  to  migrate  by FN (Ali  and 
Hynes,  1978; Donaldson and Mahan,  1983; Takashima  et 
al.,  1986). FN is a chemoattractant  stimulus  for endothelial 
cells (Bowersox and Sorgente,  1982), whereas FN fragments 
are chemotactic for macrophages (Norris et al., 1982; Clark 
et al.,  1988). 
The antibody localization  methods used to demonstrate 
FN in healing tissue do not allow a more precise definition 
of the role of FN. First, identification  in wounds of an ex- 
tracellular  molecule  does  not  distinguish  between  local 
secretion and extravasation from plasma. Second, it is likely 
that  multiple  forms of FN are present,  as the primary FN 
gene transcript  can be alternatively  spliced in three regions. 
These multiple  forms may each play different  roles in cell 
movement,  but can not be distinguished  by the antibodies 
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pared against intact FN and will therefore recognize epitopes 
present on all forms of FN. The potential molecular hetero- 
geneity resulting from alternative splicing of mRNA for rat 
FN is illustrated in Fig.  1. The three spliced segments are 
shown; two, designated EIIIA and EIIIB, represent part of 
the series of so-called type III repeats that constitute the cen- 
tral portion of the molecule while the third, V, represents a 
nonhomologous segment lying between two type III repeats 
(Hynes, 1985).  EIIIA and EIIIB can either be included or 
excluded, whereas the V region in the rat can be partially or 
completely included (depending on the choice of splice site 
used) to generate inserts of 95 or 120 amino acids (Fig.  1) 
(Schwarzbauer et al., 1983; Hynes, 1985; Kornblihtt et al., 
1985; Paul et al.,  1986; Schwarzbauer et al., 1987; Norton 
and Hynes, 1987).  As a result of this splicing, 12 potential 
forms of rat FN can be generated. At least in the human and 
chicken,  the  potentially excluded  V  region  contains cell 
adhesion sites (Humphries et al.,  1986, 1987, 1988),  sug- 
gesting that some of these different forms may be function- 
ally distinct from each other. 
In this study, we have addressed these questions of synthe- 
sis and splicing during wound healing by using in situ hybrid- 
ization with probes that either recognize all forms of FN 
mRNA or that are specific for the different spliced variants. 
We find that the level  of FN mRNA present in wounds is 
much greater than that found in normal adult rat skin. Also, 
the FN  mRNA in the wound shows  a  pattern of splicing 
different from that in normal skin and similar to that found 
in the early embryo.  As well as allowing a  more precise 
definition of the patterns of FN synthesis in wound repair, 
these results suggest that FN splicing is used as a mechanism 
to create functionally appropriate forms of FN that facilitate 
the process of wound healing. 
Materials and Methods 
Preparation of 1Issue 
4-ram punch biopsy lesions were made in the flanks of female adult rats 
(150-200 g, CD rats, Charles River Laboratories, Inc., Wilmington, MA), 
which had been anaesthetised with 25 mg/kg ketamine HCI and 5 mg/kg 
xylazine. At intervals (1, 2, 4, 7 and 14 d) after biopsy, rats were killed and 
wound sites were excised. Individual rats were used for each wound and 
control tissue was taken from unwounded rats. 
Excised wound tissue was immersed in ice-cold 5% glacial acetic acid, 
4% formaldehyde, and 85% ethanol for 15-30 min and bisected; fixation 
was continued for a total of 3-4 h. Tissues were then dehydrated in ascend- 
ing concentrations of ethanol and embedded in paraffin (Paraplast Xtra; 
Polysciences, Inc., Warrington, PA). 7-tim microtome sections were mount- 
ed on glass slides that had been pretreated with  10%  TESPA (3-amino- 
propyl-triethoxysilane) in toluene for 1 h at 80°C, washed in toluene, and 
activated by immersion in 4%  formaldehyde for 1 h (after Berger,  1986, 
modified as suggested by Dr.  D. Melton, Harvard University, Cambridge, 
MA). The slides were left on a warm plate at 45°C overnight before use. 
Preparation of  Probes  for In Situ Hybridization 
To synthesize the probes used in this study,  fragments of DNA from larger 
clones and corresponding either to a  region in the type-I repeats near the 
COOH-terminal end of FN always included in the final transcript, or to parts 
of the EIIIA-, EIIIB-, or V95-spliced regions were subeloned into pGEM 
plasmids to allow the synthesis of both sense and antisense probes. The 
lengths of the DNA inserts were 270, 213, 209, and 250 nucleotides (nt) for 
the segments C, EIIIA, EIIIB,  and V95, respectively (see Fig.  1). 
Single-stranded  RNA  probes  labeled  to  a  specific activity  of '~10  s 
cpm//xg with [35S]-UTP were synthesized using a commercially available 
transcription kit (Promega Biotec, Madison, WI). After the synthesis, all 
probes were purified on denaturing polyacrylamide gels and used without 
any reduction in length by alkaline hydrolysis (Angerer et al.,  1987). 
In Situ Hybridization 
Prehybridization and hybridization were performed as previously described 
(ffrench-Constant and Hynes, 1988).  In brief, slides were dewaxed and se- 
quentially passed through 0.2 M HCI, 1 #g/ml proteinase K, 0.2% glycine, 
4%  paraformaldehyde,  and  1/200  (vol/vol)  acetic  anhydride  in  0.1  M 
triethanolamine, pH 8.0, before addition of the hybridization mixture. Hy- 
bridization buffer (50% deionized formamide, 10% dextran sulfate, 0.3 M 
NaCI, 10 mM Tris [pH 7.6], 5 mM EDTA, 0.02 % [wt/vol] Ficol1400, 0.02 % 
[wt/vol] polyvinylpyrolidone, 0.02%  [wt/vol] BSA, 10 mM DTT,  100 ~tg/ml 
yeast tRNA, and 500 #M nonradiolabeled thio-UTP) containing the appro- 
priate probe at a concentration of 0.3/~g/ml per kb probe complexity was 
adjusted to a pH of  6.0 and placed on the sections. This probe concentration 
is the same as that used in our studies on FN mRNA distribution in chicken 
embryos (ffrench-Constant and Hynes,  1988,  1989).  In those studies we 
found that higher probe concentrations produced higher backgrounds with- 
out any further increase in signal (unpublished observations). 0.3 #g/ml per 
kb probe complexity therefore represents a suitable probe concentration that 
is sufficient to saturate target FN mRNAs even in early embryonic cell types 
that express abundant FN mRNA (ffrench-Constant  and Hynes, 1988), and 
for this reason it was chosen for the present study on v,~und healing. After 
hybridization overnight at 50°C, slides were rinsed in 50% formamide, 2 x 
SSC, 10 mM DTT at 50°C, digested with 10 ~tg/ml RNase A (type ILIA; 
Sigma Chemical Co., St. Louis, MO), and then washed in 50% formamide, 
2×  SSC,  10 mM IYI'T at 65°C as before. Slides were then dried, dipped 
in Kodak NTB-2 emulsion (diluted  1:1  in water) and exposed for 7 d  at 
-20°C, after which time they were developed in Kodak D19, fixed, stained 
with 0.02 % toluidine blue, and mounted with DPX mountant. Sections were 
viewed  on  Zeiss  Universal  or  Axiophot  microscopes  equipped  with 
brightfield and darkfield optics, and photographed on Tech Pan  film at 
85ASA. 
Results 
FN Gene Expression and Splicing in Normal Skin 
To determine the localization ofFN mRNA in rat tissue sec- 
tions, we hybridized these sections with an antisense 3~S-la- 
beled RNA probe synthesized as described in Materials and 
Methods. The template used was a 270-nt  segment corre- 
sponding to a region in the type-I repeats near the COOH- 
terminal end of  the molecule (Fig. l). This region is included 
in all known forms ofFN mRNA and the antisense probe can 
therefore be used to detect all the different spliced variants 
of FN mRNA. 
When this probe (designated FN-C) was hybridized to sec- 
tions of normal skin, specific labeling of scattered cells was 
observed in the deep (reticular) dermis and in the subjacent 
adipose tissue (Fig. 2). Often, labeled cells were found sur- 
rounding the base of hair follicles (not shown). In addition, 
labeled cells were seen in a narrow band just superficial to 
the striated muscle layer (panniculus carnosus) and occa- 
sionally between fibers within this muscle itself (Fig.  2). 
More extensive labeling was present in the thin layer of con- 
nective  tissue  deep  to  the  muscle  layers  (Fig.  2).  The 
epidermis and superficial (papillary) dermis were not la- 
beled.  The  specificity  of this  hybridization  pattern  was 
confirmed by the absence of labeling with a sense probe syn- 
thesized from the same construct (data not shown). 
We next determined the splicing pattern of FN mRNA in 
normal skin. Sections were incubated with antisense probes 
synthesized using DNA fragments from the EIIIA, EIIIB, 
and V95 regions as templates (probes designated FN-EIIIA, 
FN-EIIIB, and FN-V95, as shown in Fig.  1).  These probes 
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II  Figure 1. A diagrammatic representation of rat FN 
showing the three  regions of alternative splicing 
and illustrating the potential heterogeneity that can 
be generated by this mechanism.  The four probes 
used  in this study are shown; note that the V95 
probe cannot distinguish the V95 and V120 forms 
of FN. 
were of similar length (213,  209,  and 250 nt,  respectively) 
to the 270-nt FN-C probe. As shown in Fig. 1, the V95 region 
is included  in the mRNA encoding both the 95- and  120- 
amino  acid  insert,  so  these  two  forms cannot  be  distin- 
guished by the FN-V95 probe. 
No significant labeling was found with the FN-EIIIA or 
FN-EIIIB probes, whereas the FN-V95 probe labeled normal 
skin in a  pattern similar to that seen with the FN-C probe 
(Fig. 2). No labeling of sections of normal skin was seen with 
a  sense probe synthesized from the FN-V95 construct (not 
shown).  All these probes are of similar length and specific 
activity and were used at the same concentration in the hy- 
bridization  reactions.  The  absence  of labeling  with  FN- 
EIIIA and FN-EIIIB indicates,  therefore, that the majority 
of the FN mRNA that is present in scattered cells within the 
dermis and muscle of normal adult rat skin lacks these two 
segments. In contrast, the V segment is included in this FN 
mRNA. However, the semiquantitative nature of in situ hy- 
bridization does not allow an accurate determination of the 
extent of this inclusion. 
Figure 2.  Four closely adjacent sections of normal adult rat skin hybridized with the FN-C,  FN-EIIIA, FN-EIIlB, and FN-V probes as 
indicated, and then viewed with darkfield optics (B-E). A representative section viewed with brightfield optics is shown (.4). Scattered 
labeling with FN-C is seen in the reticular dermis (DE), whereas the epidermis (El)) is unlabeled.  Labeling is also seen on either side 
of the striated muscle layer (M) below the dermis, and occasionally within the muscle itself. The segment-specific probes show an identical 
pattern of labeling with FN-V, but no labeling with FN-EIIIA or FN-EIIIB, suggesting that the FN mRNA in normal rat skin is A-B-V  +. 
Bar, 200 ~tm. 
ffrench-Constant  et al. Fibronectin Splicing in  Wounds  905 l~gure 3.  A section through one edge of a 2--d wound, hybridized with FN-C and viewed with brightfield (A) and darkfield (B) optics. 
Extensive scattered labeling is seen in the dermis (DE) and muscle (M). Labeling is also seen at the base (hollow  arrows) and edge (arrows) 
of  the wound as well as in the uninjured dermis lateral to the wound (DE). Note that the epidermal cells (EP)  have not yet started to migrate 
centrally. They will migrate down the edge and over the base of the wound during healing.  Bar, 200 #m. 
FN Gene Expression after Wounding 
Skin punch biopsy wounds provide a well-defined and repro- 
ducible  experimental  model  (Clark  and  Henson,  1988). 
Wounding to the level of the deep reticular dermis is followed 
immediately by the coagulation of blood and extravasated 
plasma fibrinogen and FN, forming a gel that serves as provi- 
sional matrix. This matrix is invaded initially (within hours) 
by neutrophils and later by monocytes/macrophages; among 
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edge of a  4-d wound hybridized 
with FN-C and viewed as in Fig. 
3.  Epidermal  cells  (EP) have 
now migrated into the base of the 
wound. As in 2-d wounds,  labeled 
cells are found in the lateral der- 
mis (DE), muscle (M), base (hol- 
low arrows), and edges (arrows) 
of the wound. Note, however, that 
the labeling of the granulation tis- 
sue (GT) at the base is more in- 
tense  and  widespread  than  was 
seen at 2 d.  Bar,  200 #m. 
their many functions, these inflammatory cells debride dead 
tissue and phagocytose bacteria.  Epidermal keratinocytes at 
the wound edge proliferate and migrate inwardly  (centripe- 
tally) over the provisional matrix, participate in the genera- 
tion of a  new basement membrane,  and  restore a  complete 
epidermis within 7 d.  Inflammatory cells decline in number 
(over days)  as  fibroblasts  and  endothelial  cells  invade  the 
wound  bed,  forming  highly  vascular  granulation  tissue. 
Granulation tissue, in turn, is remodeled and, with the laying 
down of interstitial collagens,  is transformed into dense scar 
tissue  (over weeks). 
Healing wound  sites were examined  l,  2,  4,  7,  and  14  d 
ffrench-Constant  et al.  Fibronectin  Splicing  in  Wounds  907 after wounding, and the distribution of FN mRNA was deter- 
mined by hybridization with the FN-C probe. At  1 and 2 d 
(day 2,  shown in Fig.  3) the wound,  which extended deep 
into  the  reticular  dermis,  was  covered  with  a  desiccated 
blood clot.  FN-C labeling was seen in cells that formed a 
band in the wound bed immediately beneath this clot. In ad- 
dition, many more labeled cells were seen in the neighboring 
dermis and subjacent striated muscle than had been observed 
in normal skin (compare Fig. 3 with Fig. 2). Two differences 
were observed between the labeling of the wounds at 1 and 
2 d.  First,  labeling was more intense and extensive on day 
2. Second, at 2 d, labeling was particularly marked in cells 
immediately beneath the wound in the region over which the 
epidermal cells will migrate centripetally to cover the wound 
(Fig.  3). 
At 4 d (Fig. 4) the epidermis had migrated centrally to be- 
gin to cover the wound. Widespread and intense cell labeling 
was seen in the granulation tissue which had now formed at 
the base of the wound. As at 2 d, numerous labeled cells were 
seen in the neighboring dermis and muscle (Fig. 4), extend- 
ing a greater distance from the wound than at 2 d.  In addi- 
tion, labeled cells continued to be present in the superficial 
dermis at the edge of the wound (Fig. 5).  In contrast,  how- 
ever, the epidermal cells themselves were unlabeled at all 
times (Figs.  4  and 5). 
By 7 d (Fig. 6) the wound area was smaller, reflecting some 
degree of wound contraction,  and,  in addition,  the wound 
was  now  closed,  being  completely covered  by  epidermal 
cells.  The underlying granulation tissue appeared as a dis- 
crete triangular zone rich in blood vessels and newly depos- 
ited collagen.  Cells of the granulation tissue were still  in- 
tensely  labeled,  but  labeling  was  now  less  extensive  in 
neighboring  dermis  and  muscle  than  at  earlier  intervals 
(compare Fig.  6  with Figs.  3  and 4). 
At the latest time studied,  14 d  (not shown),  labeling of 
granulation  tissue  (now  still  further  reduced  in  area)  was 
considerably less  intense  than at 7  d  and the extent of la- 
beling in adjacent tissues was reduced to normal levels. No 
labeling of any of these regions at any time during healing 
was seen with a sense probe synthesized from the FN-C tem- 
plate, confirming the specificity of the labeling. 
These results with the FN-C probe therefore demonstrate 
increased FN mRNA levels after wounding in two locations; 
in the base and edge of the wound,  and in cells present in 
the  uninjured  dermis  and  muscle  1-2  mm  lateral  to  the 
wound. 
FN Splicing after Wounding 
The pattern of alternative  splicing  of FN  mRNA in  these 
wounds was determined by hybridizing sections with the FN- 
EIIIA, FN-EIIIB, and FN-V95 probes (Fig. 7). As in normal 
skin, FN-V95 labeled wound sections in a pattern identical 
with that seen with FN-C at all of the time intervals examined 
(compare Fig. 7 with Fig. 4). In contrast with our results in 
normal skin, however, labeling was now also found with the 
FN-EIIIA and FN-EIIIB probes at all the different stages ex- 
amined (shown for the 4-d wound in Fig.  7).  This labeling 
was largely restricted to the granulation tissue at the base of 
the wound and to the cells of the superficial dermis at the 
edge of the wound over which epidermal cell migration oc- 
curs. Unlike the results with FN-C or FN-V95, a significantly 
lower level of labeling  was seen in  the  muscle and  in the 
dermis lateral to the wound (compare Figs. 7 and 8 with Fig. 
4). In addition to this restricted distribution of FN-EIIIA and 
FN-EIIIB labeling,  we  found  that  the  labeling  with  FN- 
EIIIA was always more intense than that with FN-EIIIB (Fig. 
7).  As these two probes were virtually identical  in length, 
Figure  5. A section of  a 4-d wound shown at a higher magnification than that of Fig. 4 to demonstrate the migrating epidermal cells dissecting 
between the desiccated clot and wound base. The section has been hybridized with FN-C and viewed with brightfield (A) and darkfield 
(B) optics as in Fig. 3. Note that the section shows the opposite edge of a wound from that in Figs. 3 and 4, and the direction of migration 
is therefore left to right. Intense labeling is seen in the granulation tissue (GT) under the migrating epidermal cells (EP), and also in the 
immediately adjacent dermal cells (DE). Note, however, that the epidermal cells themselves are unlabeled (asterisks). The low level of 
labeling seen above the epidermal cells represents nonspecific binding of the FN-C probe to the clot covering the wound, and was also 
observed  in the sense controls  (not shown). Bar, 50 ~m. 
The Journal of Cell Biology, Volume  109,  1989  908 Figure 6.  A  section through an entire day 7  wound hybridized and viewed as in Figs.  3  and 4.  The smaller wound area than that seen 
at 4  d  reflects wound contraction between the two times.  The granulation tissue (GT) (blood vessel indicated by a bold arrow) remains 
intensely labeled.  Labeled cells in the muscle (M) and dermis (DE) are less numerous than at 2  and 4  d.  Note that the epidermis (EP) 
now completely covers the wound and remains unlabeled.  Bar,  200 #m. 
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EIIIB  ÷ forms of FN mRNA are less abundant than EIIIA  ÷ 
forms in the area of the wound. 
No specific labeling was seen when the sections of wound- 
ed skin were hybridized with sense probes synthesized from 
the FN-EIIIA, FN-EIIIB, and FN-V constructs, confirming 
the  specificity  of these  segment-specific  probes  (data  not 
shown). 
The observed restriction of expression of EIIIA and EIIIB 
in  FN  mRNA  after  wounding  could  result  either  from  a 
splicing difference or from an overall increase in the level of 
all  variants  of FN mRNA so that a  previous undetectable 
level of EIIIA  + or EIIIB  ÷ FN mRNA was now sufficient to 
produce a  hybridization signal.  To confirm the appearance 
of a  change in alternative  splicing  we hybridized adjacent 
sections ofa 4-d wound with FN-C, FN-EIIIA, or FN-EIIIB, 
and then exposed the sections to autoradiographic emulsion 
for different periods of time such that the level of labeling 
in the wound bed and edges was as great or greater with FN- 
EIIIA or FN-EIIIB than with FN-C (Fig.  8).  If the cells in 
the adjacent dermis and muscle contain the same proportion 
of EIIIA and EIIIB in their  FN mRNA as do those at the 
wound base  and edges,  they  should  now also  label  as,  or 
Figure 7. Three closely adjacent sections  through the edge of the 
same 4-d wound as that shown in Fig. 4, illustrating the appearance 
of EIIIA  + and  EIIIB  + FN mRNA after wounding.  The sections 
were hybridized  with  the  segment-specific  probes FN-V95,  FN- 
EIIIA, and FN-EIIIB  as indicated and viewed with darkfield optics. 
FN-V95 labels  in a manner identical  to FN-C (shown  in Fig.  4), 
with intense labeling both of the wound base and edge (hollow ar- 
row) as well as of  adjacent dermis (DE) and muscle (M). FN-EIIIA 
also labels the base and edges of the wound, but shows a more re- 
stricted  distribution  with little  labeling  of the muscle (M) and of 
the dermis (DE). FN-EIIIB labels the same areas as FN-EIIIA but 
with a lower intensity. Note that the connective tissue layer under 
the muscle (arrowheads) remains  A-B-V  + after wounding.  Bar, 
500 #m. 
Figure 8. Three closely adjacent  sections through the base of a 4-d wound hybridized with FN-C, FN-EIIIA, and FN-EIIIB, exposed for 
1, 2, and 7 d, respectively,  and then viewed  with darkfield  optics (B-D). A representative  section  is shown in brightfield  optics (.4). As 
explained  in the text, the absence of labeling  in the dermis (DE) and muscle (M) with FN-EIIIA and FN-EIIIB in the presence of more 
intense labeling  in the base of the wound (hollow arrow) with these probes than with the FN-C probe shows that the restricted  exoression 
of EIIIA and EIIIB after wounding reflects a difference  in RNA splicing  between  the two regions.  Bar,  300 #m. 
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However, in these experiments the restricted distribution of 
EIIIA and EIIIB was still seen, with little labeling outside 
the base and edges of the  wound (Fig.  8).  We conclude, 
therefore, that the observed pattern of labeling with the splice 
segment-specific  probes  reflects  a  splicing  difference in 
which EIIIA and EIIIB are included in the FN mRNA at the 
base and sides of the wound to a greater degree than they are 
in normal skin or in cells more distant from the wound. 
Discussion 
To determine the patterns ofFN gene expression and splicing 
in healing wounds, we performed in situ hybridization on tis- 
sue sections of normal rat skin and wounds at different times 
during healing, using probes that recognize either total FN 
mRNA  or  mRNA  containing  the  individual  spliced  seg- 
ments. We found a low but significant level of FN mRNA in 
normal skin localized to scattered individual cells in the re- 
ticular dermis and to cells adjacent to and within the pannic- 
ulus carnosus. In wounded skin, by contrast, extensive ex- 
pression of FN mRNA was found at the base and edges of 
the wound, extending into the adjacent uninjured dermis and 
to the underlying muscle. This increased level of FN mRNA 
was evident within 1 d after wounding, with the highest levels 
seen at the fourth and seventh day. Analysis of the splicing 
pattern showed that this FN mRNA was spatially heteroge- 
neous. Cells at the base and edges of the wound expressed 
mRNA that included both of the alternatively spliced EIIIA 
and EIIIB regions; in contrast, mRNA expression in adja- 
cent dermis and muscle showed the same splicing pattern as 
that  seen  in  normal  skin;  that  is,  EIIIA  and  EIIIB were 
largely excluded. Thus, (a) wounding induces increased lev- 
els of FN mRNA both directly beneath the wounded area and 
in adjacent dermal tissue; and (b) the pattern of splicing of 
FN mRNA locally in the wound bed, but not that in contigu- 
ous but more distant sites, differs from that in normal skin. 
These results are consistent with previous immunolocal- 
ization studies of FN in normal and wounded skin. Studies 
in normal rat skin have demonstrated FN surrounding hair 
follicles in the dermis (Couchman et al., 1979) and reported 
either a low or undetectable level of FN in the normal epider- 
mal basement membrane (Couchman et al.,  1979; Clark et 
al.,  1983).  After wounding, FN levels are reported to rise 
substantially at the base and edges of the wound (Grinnell et 
al.,  1981; Clark et al.,  1982a,  b).  At  least  some of this 
FN is apparently synthesized by cells in the immediate vicin- 
ity of the wound, as studies using mice in which well-healed 
transplants of rat skin were wounded have shown that locally 
synthesized (rat) FN is present in the zone of healing (Clark 
et al., 1983). These studies also showed that rat FN was less 
abundant than the mouse pFN for the first 4 d after wounding 
(Clark et al.,  1983). However, our results show a dramatic 
early increase in FN mRNA at the base of the wound, and 
in the dermis forming the edge of the wound. This suggests 
that locally produced FN is present from the earliest stages 
of healing.  Moreover,  this  locally produced FN  contains 
spliced segments not present in the pFN that constitutes the 
majority form of FN at these early stages. We hypothesize 
that these new forms of FN may perform qualitatively differ- 
ent functions. 
A central event in healing skin wounds is the inward migra- 
tion of epidermal cells from the wound edges to cover the in- 
jured  surface.  As judged by immunohistochemistry, these 
migrating cells are underlain by an irregular band of fibrin 
and FN (Clark et al.,  1982a; Clark et al.,  1983; Dvorak et 
al.,  1984).  This is in contrast to the situation in normal, 
uninjured skin where the epidermal basal lamina contains lit- 
tle or no fibrin or FN (Couchman et al.,  1979). The source 
of the FN associated with migrating keratinocytes has not 
been established,  and it could be derived from plasma or 
from local synthesis by epidermal or dermal cells. 
A striking feature observed in our study was the expres- 
sion of FN by cells disposed at the base and edges of the 
wound just beneath the epidermis; this FN mRNA expres- 
sion preceded the inward migration of epidermal cells that 
eventually covered the wound.  FN-coated glass coverslips 
inserted under the  skin of newts  are  reported to promote 
epidermal  cell migration  (Donaldson and  Mahan,  1983). 
Epidermal cells also express a  140-kD FN receptor similar 
to fibroblast FN receptors (Toda et al., 1987; Grinnell et al., 
1987). It seems likely that expression of this epidermal cell 
receptor is increased after wounding, as these cells show in- 
creased adhesion to FN while migrating over a wound base 
(Takashima et al.,  1986) and the Arg-Gly-Asp-Ser (RGDS) 
peptide,  which inhibits the binding of FN by the integrin 
receptors (Ruoslahti and Pierschbacher,  1987) can prevent 
epidermal cell migration after wounding (Donaldson et al., 
1987). Together, these findings suggest that the cells contain- 
ing FN mRNA at the wound edges synthesize a matrix which 
forms a pathway of FN. This pathway may then be followed 
by migrating epidermal cells expressing integrin receptors 
that bind this FN. Our observation that neither migrating nor 
normal  epidermal  cells  express  significant  levels  of FN 
mRNA suggests that they are not responsible for the synthe- 
sis of the FN over which they migrate. Instead, without com- 
petition by endogenous FN,  receptors on epidermal cells 
may then be maximally responsive to FN encountered within 
the pathway. 
Our finding that epidermal cells migrating over the wound 
bed contain little or no FN mRNA in vivo is in contrast with 
in vitro studies, in which these cells synthesize FN (Alitalo 
et al.,  1982;  Clark et al.,  1985;  Kariniemi et al.,  1982; 
O'Keefe et al., 1984, 1987; Kubo et al., 1987), and illustrates 
the caution required when extrapolating from in vitro models 
of wound healing to the in vivo situation.  It is important, 
therefore, to establish the source(s) of FN in vivo. Although 
keratinocytes do not appear to express FN mRNA at any 
time, present methods have not yet permitted us to determine 
the respective roles played by individual inflammatory cells 
or dermal fibroblasts in producing the various types of FN 
synthesized during repair. Healing wounds are infiltrated by 
a heterogeneous population of inflammatory cells as well as 
by activated connective tissue cells. Methods for improving 
the preservation of tissue morphology to extend positive cell 
identification are currently under development. 
The demonstration that the pattern of FN splicing in the 
area of the healing wound is different from that in normal 
skin is a major finding of this study. In normal skin all FN 
mRNA  appears  to be EIIIA-,  EIIIB-,  but in  wounds  we 
found  EIIIA  ÷ and/or  EIIIB  ÷ FN  mRNA  localized to  the 
wound base and edges at all stages after wounding. This is 
particularly interesting in light of our recent demonstration 
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FN  mRNA  present  in  the  early  (embryonic  days  2-4) 
chicken embryo (ffrench-Constant and Hynes, 1988),  when 
there is active proliferation and migration of cells. However, 
the EIIIA and EIIIB regions are spliced out in tissue-specific 
patterns after embryogenesis and organogenesis have been 
largely completed (ffrench-Constant and Hynes, 1989).  Al- 
though we have not examined embryonic rat FN  mRNA 
directly, the patterns of FN splicing appear to be highly con- 
served among species; for example, hepatocytes synthesizing 
pFN and fibroblasts synthesizing cellular FN in culture show 
identical  splicing patterns  in  chickens,  rats,  and humans 
(Schwarzbauer et al.,  1983, 1987; Kornblihtt et al.,  1985; 
Sekiguchi et al.,  1986;  Norton and Hynes, 1987).  It there- 
fore seems likely that the early rat embryo, like the chicken, 
contains predominantly EIIIA  ÷, EIIIB  ÷ FN mRNA and that 
the results observed in this study reflect a reappearance of 
an embryonic pattern of FN splicing. Previous observations 
show that the pattern of FN mRNA splicing in cultured cells 
is accurately reflected in the FN synthesized by these cells 
(Tamkun and Hynes, 1983; Price and Hynes, 1985; Paul et 
al., 1986; Schwarzbauer et al., 1987).  Therefore, our study 
provides evidence that splicing of FN mRNA during wound 
healing leads to different, and possibly functionally more ap- 
propriate, forms of FN than are present either from plasma 
or from nearby cells that do not alter their pattern of splicing 
from that seen in normal skin. 
Although these  results do not address  the actual  func- 
tion(s) of the EIIIA  ÷,  EIIIB  ÷ FN,  the localization of this 
form of FN at the base and sides of the wound is consistent 
with a role in epithelial cell migration. In keeping with this, 
EIIIA  +,  EIIIB  + FN is widespread in the embryo at a time 
when many different cell migrations are in progress (Norton 
and Hynes, 1987; ffrench-Constant and Hynes, 1988). How- 
ever,  other functions for this form of FN such as a role in 
cell proliferation and differentiation or in chemotaxis obvi- 
ously should not be excluded. 
The mechanisms responsible for controlling the pattern of 
splicing change are unknown. However,  TGF-/3, which in- 
creases the synthesis of both FN and its integrin receptor (Ig- 
notz et al., 1987; Ignotz and Massague, 1987; Raghow et al., 
1987; Roberts et al.,  1988),  has been shown by analyses of 
FN protein to increase the inclusion of EIIIA in FN (Baiza 
et al., 1988).  This growth factor has been proposed to play 
an important role in wound healing, as the subcutaneous in- 
jection of TGF-13 produces a cellular response which mimics 
the formation of granulation tissue found during wound heal- 
ing (Roberts et al., 1986). TGF-/3 is found in high concentra- 
tions in platelets (Assoian et al., 1983) and would therefore 
be expected to be released at the site of wounding, and TGF-/3 
mRNA has also been demonstrated in the macrophages pres- 
ent in a wound (Rappolee et al., 1988). It seems likely, there- 
fore, that this and other growth factors will be involved in 
the molecular and cellular mechanisms of healing and fur- 
ther in vitro studies of their role in the FN RNA splicing as- 
sociated with wound healing are clearly warranted. 
The finding that all detectable FN mRNA in normal skin 
was EIIIA-, EIIIB- was unexpected, as this pattern of FN 
splicing has been considered a characteristic ofpFN (Hynes, 
1985;  Schwarzbauer et al.,  1987; Gutman and Kornblihtt, 
1987;  Zardi et al.,  1987).  Given the correlation between 
these in situ hybridization results and the pattern of FN label- 
ing using immunolocalization, it seems likely that EIIIA-, 
EIIIB- FN is synthesized in normal adult skin and depos- 
ited in the local matrix. This result raises the possibility that 
splicing of the V region, rather than of EIIIA or EIIIB, may 
represent an important difference between soluble pFN, syn- 
thesized in the liver, and locally produced "cellular" FN. V 
is included in only 50 % of pFN mRNA (Tamkun and Hynes, 
1983;  Schwarzbauer et al.,  1983, 1987; Paul and Hynes, 
1984; Paul et al., 1986; Norton and Hynes, 1987), whereas 
it appears  to be  present  in the great majority of the  FN 
mRNA  present  in  embryos  (Norton  and  Hynes,  1987; 
ffrench-Constant and Hynes, 1988).  In addition, our quan- 
titative study of FN mRNA in  16-d chicken embryo using 
ribonuclease protection experiments found apparently com- 
plete V region inclusion in all tissues examined except the 
liver, which synthesizes pFN (ffrench-Constant and Hynes, 
1989). In this study, the level of inclusion of V95 appears to 
be high, as judged by labeling intensity (Figs. 2 and 7), al- 
though more quantitative analyses such as nuclease protec- 
tion are needed to strengthen this conclusion. Further studies 
of V  region splicing,  and in particular of the V25  region 
which was not examined in our study but which can be alter- 
natively spliced in hepatocytes and fibroblasts (Paul et al., 
1986), are required to determine the contribution of this re- 
gion to the properties of FN. 
The synthesis of EIIIA  +, EIIIB  + "embryonic-type" FN af- 
ter wounding suggests that the EIIIA-, EIIIB- pFN, which 
is present as a result of exudation from damaged vessels and 
which represents the most abundant form of FN until at least 
the fourth day after wounding (Clark et al., 1983),  may not 
be  sufficient for satisfactory healing. This point has ther- 
apeutic implications, as a number of clinical trials have at- 
tempted to accelerate wound healing using exogenously ap- 
plied pFN (Clark,  1988;  Grinnell et al.,  1988).  In light of 
our results, it seems likely that FN containing both EIIIA and 
EIIIB might provide the most efficient acceleration of wound 
repair. 
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